AAAAAA

   
Results: 1-11 |
Results: 11
PHARMACOKINETICS OF CI-1007, AN INVESTIGATIONAL ANTIPSYCHOTIC DRUG, IN CYTOCHROME-P450 2D6 EXTENSIVE METABOLIZERS
Authors: FENG MR BROWN R UNDERWOOD B POSVAR EL ELDON MA
Citation: Mr. Feng et al., PHARMACOKINETICS OF CI-1007, AN INVESTIGATIONAL ANTIPSYCHOTIC DRUG, IN CYTOCHROME-P450 2D6 EXTENSIVE METABOLIZERS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 52-52
SAFETY, TOLERANCE, AND PHARMACODYNAMICS OF CL-1007, A NEW DOPAMINE AUTORECEPTOR AGONIST, IN HEALTHY-SUBJECTS
Authors: ELDON MA UNDERWOOD BA POSVAR EL FENG R WRIGHT DS SEDMAN AJ
Citation: Ma. Eldon et al., SAFETY, TOLERANCE, AND PHARMACODYNAMICS OF CL-1007, A NEW DOPAMINE AUTORECEPTOR AGONIST, IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 44-44
TOLERANCE AND PHARMACOKINETICS OF SINGLE-DOSE ATORVASTATIN, A POTENT INHIBITOR OF HMG-COA REDUCTASE, IN HEALTHY-SUBJECTS
Authors: POSVAR EL RADULOVIC LL CILLA DD WHITFIELD LR SEDMAN AJ
Citation: El. Posvar et al., TOLERANCE AND PHARMACOKINETICS OF SINGLE-DOSE ATORVASTATIN, A POTENT INHIBITOR OF HMG-COA REDUCTASE, IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 36(8), 1996, pp. 728-731
MULTIPLE-DOSE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF ATORVASTATIN, AN INHIBITOR OF HMG-COA REDUCTASE, IN HEALTHY-SUBJECTS
Authors: CILLA DD WHITFIELD LR GIBSON DM SEDMAN AJ POSVAR EL
Citation: Dd. Cilla et al., MULTIPLE-DOSE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF ATORVASTATIN, AN INHIBITOR OF HMG-COA REDUCTASE, IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 60(6), 1996, pp. 687-695
HEMODYNAMIC AND HORMONAL EFFECTS OF QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: MITROVIC V MUDRA H BONZEL T SCHMIDT W STRAND JC BAKOVICALT R POSVAR EL
Citation: V. Mitrovic et al., HEMODYNAMIC AND HORMONAL EFFECTS OF QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 686-698
EFFECT OF FOOD ON THE BIOAVAILABILITY OF ATORVASTATIN, AN HMG-COA REDUCTASE INHIBITOR
Authors: RADULOVIC LL CILLA DD POSVAR EL SEDMAN AJ WHITFIELD LR
Citation: Ll. Radulovic et al., EFFECT OF FOOD ON THE BIOAVAILABILITY OF ATORVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, Journal of clinical pharmacology, 35(10), 1995, pp. 990-994
THE PHARMACOKINETICS OF QUINAPRIL AND QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: BEGG EJ ROBSON RA IKRAM H RICHARDS AM BAMMERTADAMS JA OLSON SC POSVAR EL REECE PA SEDMAN AJ
Citation: Ej. Begg et al., THE PHARMACOKINETICS OF QUINAPRIL AND QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, British journal of clinical pharmacology, 37(3), 1994, pp. 302-304
THE TEMPORAL EFFECT OF FOOD ON TACRINE BIOAVAILABILITY
Authors: WELTY DF SIEDLIK PH POSVAR EL SELEN A SEDMAN AJ
Citation: Df. Welty et al., THE TEMPORAL EFFECT OF FOOD ON TACRINE BIOAVAILABILITY, Journal of clinical pharmacology, 34(10), 1994, pp. 985-988
LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE (VOL 35, PG 155, 1994)
Authors: RADULOVIC LL WILDER BJ LEPPIK IE BOCKBRADER HN CHANG T POSVAR EL SEDMAN AJ UTHMAN BM ERDMAN GR
Citation: Ll. Radulovic et al., LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE (VOL 35, PG 155, 1994), Epilepsia, 35(3), 1994, pp. 707-707
LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE
Authors: RADULOVIC LL WILDER BJ LEPPIK IE BOCKBRADER HN CHANG T POSVAR EL SEDMAN AJ UTHMAN BM ERDMAN GR
Citation: Ll. Radulovic et al., LACK OF INTERACTION OF GABAPENTIN WITH CARBAMAZEPINE OR VALPROATE, Epilepsia, 35(1), 1994, pp. 155-161
LACK OF EFFECT OF GABAPENTIN ON THE PHARMACOKINETICS OF A NORETHINDRONE ACETATE ETHINYL ESTRADIOL-CONTAINING ORAL-CONTRACEPTIVE
Authors: ELDON MA UNDERWOOD BA RANDINITIS EJ POSVAR EL SEDMAN AJ
Citation: Ma. Eldon et al., LACK OF EFFECT OF GABAPENTIN ON THE PHARMACOKINETICS OF A NORETHINDRONE ACETATE ETHINYL ESTRADIOL-CONTAINING ORAL-CONTRACEPTIVE, Neurology, 43(4), 1993, pp. 307-308
Risultati: 1-11 |